Voloridge Investment Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-243,525
Closed -$3.18M 1317
2024
Q4
$3.18M Buy
243,525
+47,459
+24% +$633K 0.01% 874
2024
Q3
$3.08M Sell
196,066
-90,851
-32% -$1.38M 0.01% 871
2024
Q2
$3.87M Sell
286,917
-145,541
-34% -$2.98M 0.01% 815
2024
Q1
$12M Sell
432,458
-195,269
-31% -$4.34M 0.04% 447
2023
Q4
$12.1M Buy
627,727
+383,728
+157% +$6.95M 0.05% 430
2023
Q3
$3.94M Buy
243,999
+13,363
+6% +$237K 0.02% 724
2023
Q2
$4.39M Sell
230,636
-173,607
-43% -$3.1M 0.02% 717
2023
Q1
$5.88M Buy
+404,243
New +$7.24M 0.03% 626
2021
Q3
Sell
-34,510
Closed -$1.46M 1802
2021
Q2
$1.46M Buy
+34,510
New +$1.34M 0.01% 1118
2020
Q4
Sell
-38,433
Closed -$965K 1499
2020
Q3
$965K Buy
+38,433
New +$560K 0.01% 950
2020
Q2
Sell
-21,000
Closed -$192K 1429
2020
Q1
$192K Buy
+21,000
New +$127K 0.01% 965
2019
Q4
Sell
-56,777
Closed -$330K 1287
2019
Q3
$330K Buy
+56,777
New +$255K 0.01% 901
2018
Q2
Sell
-19,321
Closed -$300K 553
2018
Q1
$300K Buy
+19,321
New +$344K 0.01% 450

Other funds holding ACH

Voloridge Investment Management's ACH Position: Q1 2025 in Review

Voloridge Investment Management sold out of Accendra Health (ACH) in Q1 2025, closing a stake of 243,525 shares — an estimated $3.18M sold.

Voloridge Investment Management first reported a position in ACH in Q1 2018 and held it in 13 quarters. The position peaked at $12.1M in Q4 2023. 242 funds tracked by Wall St. Rank hold ACH as of Q1 2025.

  • Voloridge Investment Management reported no remaining Accendra Health position as of Q1 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 243,525 Accendra Health shares in Q1 2025, an estimated $3.18M.
  • Voloridge Investment Management first reported a position in Accendra Health in Q1 2018 and held it in 13 quarters.
  • Voloridge Investment Management's Accendra Health position peaked at $12.1M in Q4 2023.
  • 242 funds tracked by Wall St. Rank held Accendra Health as of Q1 2025.

Based on Voloridge Investment Management's 13F filing for Q1 2025, filed 15 May 2025.